- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/7076 - Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
Patent holdings for IPC class A61K 31/7076
Total number of patents in this class: 2229
10-year publication summary
|
168
|
156
|
184
|
193
|
219
|
215
|
183
|
162
|
153
|
56
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Iovance Biotherapeutics, Inc. | 366 |
69 |
| Atea Pharmaceuticals, Inc. | 76 |
41 |
| Gilead Sciences, Inc. | 2190 |
32 |
| Can-fite Biopharma Ltd. | 57 |
29 |
| The Regents of the University of California | 20587 |
28 |
| Epizyme, Inc. | 357 |
28 |
| The Board of Regents of the University of Texas System | 2277 |
26 |
| Merck Sharp & Dohme LLC | 3732 |
26 |
| Chiesi Farmaceutici S.p.A. | 959 |
23 |
| Emory University | 1703 |
22 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2976 |
20 |
| Future Medicine Co., Ltd. | 36 |
18 |
| University Health Network | 1062 |
17 |
| Board of Regents, The University of Texas System | 6062 |
16 |
| Alios BioPharma, Inc. | 61 |
16 |
| Arcus Biosciences, Inc. | 162 |
16 |
| Dana-Farber Cancer Institute, Inc. | 2654 |
16 |
| Pharmacyclics LLC | 239 |
16 |
| The Johns Hopkins University | 5829 |
14 |
| Nucana plc | 74 |
14 |
| Other owners | 1742 |